The BIomarker Guided (BIG) Study for Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

January 17, 2024

Study Completion Date

February 12, 2024

Conditions
Major Depressive Disorder
Interventions
DRUG

Guanfacine Tablets

Guanfacine immediate release, sold under the brand name Tenex among others, is a medication used to treat high blood pressure and off-label to treat attention deficit hyperactivity disorder (ADHD). It is taken by mouth and will be compounded by a pharmacy to the required doses used in this study.

Trial Locations (1)

94304

Stanford Psychiatry, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER